Jun 30, 2013

Altimmune Q2 2013 Earnings Report

Total Revenue
$4.3M
Previous year: $6.32M
-32.0%
EPS
-$0.667
Previous year: -$0.667
+0.0%
Cash and Equivalents
$15.8M
Previous year: $11.8M
+34.1%
Free Cash Flow
-$541K
Total Assets
$24.6M
Previous year: $23.8M
+3.3%

Altimmune

Altimmune